Drugs / Nandrolone
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00242463 | Oct 2005 → Oct 2007 | protein-energy malnutrition | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Terminated | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00000597 | Mar 1982 → Dec 1988 | aplastic anemia, pancytopenia | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nandrolone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00242463 ↗ |
| Modality | Other / unclassified | “nandrolone (an anabolic steroid)” NCT00242463 ↗ |
| Route | Intramuscular | “a weekly intramuscular injection of nandrolone” NCT00242463 ↗ |